Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

In this report, the global catheter stabilization device market is segmented based on product, application, end user and geography. Based on products the market is segmented into arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. Based on applications the market is segmented into general surgery, cardiovascular, respiratory, urological, gastric and oropharyngeal, radiology and other applications. The end users for this market are hospitals, emergency clinics, home healthcare providers, and diagnostic centers. Based on geography the global catheter stabilization device market is segmented into North America, Europe, Asia and Rest of the World (RoW).

In this report, the global catheter stabilization device market is segmented based on product, application, end user and geography. Based on products the market is segmented into arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. Based on applications the market is segmented into general surgery, cardiovascular, respiratory, urological, gastric and oropharyngeal, radiology and other applications. The end users for this market are hospitals, emergency clinics, home healthcare providers, and diagnostic centers. Based on geography the global catheter stabilization device market is segmented into North America, Europe, Asia and Rest of the World (RoW).

Brazil Biomaterials Market includes Brazil Biomaterials Market Share, Brazil Biomaterials Market Research Report, Brazil Biomaterials Market Trade, Brazil Biomaterials Market Prices, Brazil Biomaterials Market Geography Trend and Brazil Biomaterials Market Forecast 2011-2015

The top five players in the global optical imaging market accounted for over 80% of the market share. However, the intense competition by existing small- and mid-sized players in the market is threatening the market share of top players. In order to maintain their share, leading players are continuously embracing new technologies and striving to bring advanced products into the market. This increasing competitiveness is also expected to drive innovation in the market, thereby helping the industry to solve existing challenges and meet the needs of the market.

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

As of 2015, General Electric Company (U.S.) and Vital Images, Inc. (U.S.) [now part of Toshiba Corporation (Japan)] are estimated to hold the leadership position in the global market. Other key players in this market include Agfa-Gevaert N.V. (Belgium), Carestream Health, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Qi Imaging (U.S.), Siemens AG (Germany), TeraRecon, Inc. (U.S.), and Visage Imaging, Inc. (U.S.), among others. Market players primarily focus on the development of innovative AV software, geographic expansion, and strategic acquisitions as key strategies to ensure their growth in the advanced visualization market.

The global cell counting market is mainly dominated by six players that accounted for around 65% to 70% of the global market share in 2014. However, new players in the market are intensifying competition and thereby threatening the market share of the existing players. In order to maintain their shares, leading players are continuously adopting various strategies. This increased competitiveness is expected to drive innovation in the market and thereby help the industry to solve the existing challenges.

The global biopharmaceuticals market is set to exhibit a CAGR of 7.83% during 2019-2026 and is estimated to reach a market value of US $ XX billion by 2026. Biopharmaceuticals are large and complex molecular drugs that are mainly obtained from proteins and nucleic acids of living organisms such as microorganisms and animal cells also known as transgenic organisms. These drugs are obtained using biotechnology and have high-therapeutic value. Biopharmaceuticals are also known as biologics and biotech drugs and are usually administered by intravenous, subcutaneous, or intramuscular injections and are more efficient than the conventional small molecule drugs. Biopharmaceuticals are an alternative to the previously less effective and sometimes unsafe treatments and offer several benefits. Biopharmaceuticals benefits include highly effective and potent action, fewer side effects, can be tailored according to specific medical requirements of patients and they hold the potential to actually cure diseases at the root level. Biopharmaceuticals have reduced the number of deaths due to cancer and HIV/AIDS in the past decade and have changed the treatment of several chronic diseases, such as diabetes and cardiovascular diseases. Download free Report Sample: https://www.datamintelligence.com/download-sample/biopharmaceuticals-market View Full Report Sample: https://www.datamintelligence.com/research-report/biopharmaceuticals-market

[No of Pages - 250] Browse Market tables and figures/charts on Healthcare BPO market research report evaluates the global Healthcare Business Process Outsourcing Market with respect to the services market. The report analyzes geography; forecasting revenues, and trends

Global medical electronics market report on the medical electronics market analyzes the medical electronics supply chain, giving a very clear insight of all major and supported segments to the industry. According to report the total value of medical electronics market is expected to reach $56.50 Billion by 2020, growing at a CAGR of 5.5% from 2014 to 2020.

Companion animals are domesticated or domestic-bred animals whose physical, emotional, behavioral and social needs can be readily met as companions in the home or a close daily relationship with humans. Companion animal health market mainly comprises of medicines, medicinal feed additives, and vaccines and caters to both foods producing and companion animals. China Companion Animal Health Market was worth US$ XX Million in 2019 and is expected to reach US$ XX Million by 2026, at a CAGR of XX% during the forecast period 2019-2026. Download Free Sample Report: https://www.datamintelligence.com/download-sample/china-companion-animal-health-market View Full Report Sample: https://www.datamintelligence.com/research-report/china-companion-animal-health-market

[Price: $4650] [No of pages - 346 ] Browse 142 market tables and 44 figures/charts on Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13),[SPECT/PET Radioisotopes (Technetium, F-18)] & by Geography - Forecasting - 2017

The global digital X-ray market is estimated to be worth $4.82 billion by 2018, growing at a CAGR of 4.5% from 2013 to 2018. The digital X-ray market is divided into three segments based on types, major products and applications in imaging. Based on types, the market is segmented into computed radiography and digital radiography; the latter is the fastest-growing market.

[Price: $4650] [No of Pages - 383 ] Browse market tables and figures/charts on Minimally Invasive Surgical Instruments/Devices, Imaging & Visualization Systems & Medical Robotics Market research report will analyze the market potential for minimally-invasive and non-invasive surgery.

[Price: $4650] [No of slides - 111 ] Browse market tables and figures/charts on Autologous Stem Cell & Non-stem Cell Therapy Market report includes applications of the technology and trends in terms of ACT market size and growth of autologous cellular therapies in medical treatments globally.

[201 Slides Report] Browse 133 market tables and 29 figures/charts on Magnetic Resonance Imaging (MRI) Market report categorizes the Global MRI Systems by Technology, Applications, Architecture, Field Strengths & by Geography in Medical Diagnostics with Market Landscape Analysis

[Price: $4650] [No of pages - 280 ] Browse 120 market tables and 29 figures/charts on North American Nuclear Medicine / Radiopharmaceuticals Market report segmented the North American market By Applications (Deuterium, C-13), (Cancer/Oncology, Cardiac) By Stable Isotopes, SPECT/PET Radioisotopes (Technetium, F-18) & by Geography - Forecasting -2017

[Price: $4650] [No of pages - 280 ] Browse 130 market tables and 28 figures/charts on North America Injectable Drug Delivery Market report categories North America market estimating and forecasting 2017 by Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors], Formulations [Liposomes, Microspheres, & Nanoparticles], Therapeutics [Diabetes & Oncology]& Geography

[333 Pages Report] European Injectable Drug Delivery Market report categorizes the europe market by Therapeutics [Diabetes & Oncology], by Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors], Formulations [Liposomes, Microspheres, & Nanoparticles], Market & Geography